Avrobio Inc reported -27774000 in Operating Profit for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Akebia Therapeutics AKBA:US $ 52.5M 111M
Alnylam Pharmaceuticals ALNY:US $ -191.69M 44.95M
Applied Genetic Technologies AGTC:US $ -17.72M 4.14M
Bluebird Bio BLUE:US $ -107.4M 12.95M
Epizyme EPZM:US $ -29806000 21.12M
Gilead Sciences GILD:US $ 2029M 1832M
Intercept Pharmaceuticals ICPT:US $ -13.36M 3.09M
Karyopharm Therapeutics KPTI:US $ -42908000 8.32M
Macrogenics MGNX:US $ -41808000 24.83M
Pfizer PFE:US $ 12102M 2229M
Sangamo Biosciences SGMO:US $ -45.73M 0.47M
Sarepta Therapeutics SRPT:US $ -211.13M 124.25M
Takeda 4502:JP Y 150515M 152134M